BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22790929)

  • 1. Stimulation of the amyloidogenic pathway by cytoplasmic superoxide radicals in an Alzheimer's disease mouse model.
    Murakami K; Murata N; Noda Y; Irie K; Shirasawa T; Shimizu T
    Biosci Biotechnol Biochem; 2012; 76(6):1098-103. PubMed ID: 22790929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease.
    Murakami K; Murata N; Noda Y; Tahara S; Kaneko T; Kinoshita N; Hatsuta H; Murayama S; Barnham KJ; Irie K; Shirasawa T; Shimizu T
    J Biol Chem; 2011 Dec; 286(52):44557-68. PubMed ID: 22072713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
    Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
    Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.
    Li F; Calingasan NY; Yu F; Mauck WM; Toidze M; Almeida CG; Takahashi RH; Carlson GA; Flint Beal M; Lin MT; Gouras GK
    J Neurochem; 2004 Jun; 89(5):1308-12. PubMed ID: 15147524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Wille E; Stack C; Calingasan NY; Beal MF; Lin MT
    FASEB J; 2009 Aug; 23(8):2459-66. PubMed ID: 19346295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.
    Schuessel K; Schäfer S; Bayer TA; Czech C; Pradier L; Müller-Spahn F; Müller WE; Eckert A
    Neurobiol Dis; 2005 Feb; 18(1):89-99. PubMed ID: 15649699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice.
    Esposito L; Raber J; Kekonius L; Yan F; Yu GQ; Bien-Ly N; Puoliväli J; Scearce-Levie K; Masliah E; Mucke L
    J Neurosci; 2006 May; 26(19):5167-79. PubMed ID: 16687508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.
    Bayer TA; Schäfer S; Breyhan H; Wirths O; Treiber C; Multhaup G
    Clin Neuropathol; 2006; 25(4):163-71. PubMed ID: 16866297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
    Ding Y; Zhong Y; Baldeshwiler A; Abner EL; Bauer B; Hartz AMS
    Fluids Barriers CNS; 2021 Mar; 18(1):10. PubMed ID: 33676539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease.
    Sanchez-Mejia RO; Newman JW; Toh S; Yu GQ; Zhou Y; Halabisky B; Cissé M; Scearce-Levie K; Cheng IH; Gan L; Palop JJ; Bonventre JV; Mucke L
    Nat Neurosci; 2008 Nov; 11(11):1311-8. PubMed ID: 18931664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice.
    Chin J; Palop JJ; Yu GQ; Kojima N; Masliah E; Mucke L
    J Neurosci; 2004 May; 24(19):4692-7. PubMed ID: 15140940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.
    Pappolla MA; Chyan YJ; Omar RA; Hsiao K; Perry G; Smith MA; Bozner P
    Am J Pathol; 1998 Apr; 152(4):871-7. PubMed ID: 9546346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin B degrades amyloid-β in mice expressing wild-type human amyloid precursor protein.
    Wang C; Sun B; Zhou Y; Grubb A; Gan L
    J Biol Chem; 2012 Nov; 287(47):39834-41. PubMed ID: 23024364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity.
    Lee HP; Pancholi N; Esposito L; Previll LA; Wang X; Zhu X; Smith MA; Lee HG
    PLoS One; 2012; 7(1):e28033. PubMed ID: 22276093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
    Vulin M; Zhong Y; Maloney BJ; Bauer B; Hartz AMS
    Fluids Barriers CNS; 2023 Oct; 20(1):70. PubMed ID: 37803468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer's disease via regulation of β-secretase activity.
    Lee YJ; Choi DY; Lee YK; Lee YM; Han SB; Kim YH; Kim KH; Nam SY; Lee BJ; Kang JK; Yun YW; Oh KW; Hong JT
    J Alzheimers Dis; 2012; 29(3):677-90. PubMed ID: 22330831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.